The fundamental reasons to buy this stock have been enunciated often. For you technical analysis fans, check out the 2 year or 5 year charts. The 2 year shows a textbook saucer or rounded bottom formation and the 5 years shows a great 5 year head and shoulders bottom with a target price of $25 to $27 - right near Piper-Jaffrey's target.
Mesoblast is already up 20% in Austrian trading. This is a giant step forward with a well capitalized company (CELG) to bring Prochymal to market sometime in our lifetime. Potential huge royalties to OSIR which was not a real possibility only because Mesoblast did not have the necessary capital . Now, with CELG as a partner, investor, and collaborator...look out. Suddenly, this is the real deal.